Ovarian Reserve and Serum Concentration of Thyroid Peroxidase Antibodies in Euthyroid Women With Different Polycystic Ovary Syndrome Phenotypes
Objective: It has been shown that women with polycystic ovary syndrome (PCOS), as well as Hashimoto's thyroiditis (HT), are characterized by increased incidence of infertility. Serum anti-Müllerian hormone (AMH), which reflects ovarian reserve, is elevated in PCOS women and is decreased in wome...
| Published in: | Frontiers in Endocrinology |
|---|---|
| Main Authors: | Agnieszka Adamska, Agnieszka Łebkowska, Anna Krentowska, Justyna Hryniewicka, Marcin Adamski, Monika Leśniewska, Aleksandra Maria Polak, Irina Kowalska |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-07-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2020.00440/full |
Similar Items
Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics
by: Minhthao Thi Nguyen, et al.
Published: (2023-01-01)
by: Minhthao Thi Nguyen, et al.
Published: (2023-01-01)
Anti-Müllerian hormone and luteinizing hormone for prediction of spontaneous ovulation after laparoscopic ovarian drilling in clomiphene-resistant polycystic ovary syndrome
by: Mohamed Rezk, et al.
Published: (2016-06-01)
by: Mohamed Rezk, et al.
Published: (2016-06-01)
Increased Serum AMH in a Subgroup of Women with Idiopathic Hyperandrogenism: Do These Women Have PCOS?
by: Enrico Carmina, et al.
Published: (2025-08-01)
by: Enrico Carmina, et al.
Published: (2025-08-01)
Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
by: Youran Li, et al.
Published: (2022-06-01)
by: Youran Li, et al.
Published: (2022-06-01)
The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis
by: Zhijiao Zhou, et al.
Published: (2023-06-01)
by: Zhijiao Zhou, et al.
Published: (2023-06-01)
Body Composition and Serum Anti-Müllerian Hormone Levels in Euthyroid Caucasian Women With Hashimoto Thyroiditis
by: Agnieszka Adamska, et al.
Published: (2021-07-01)
by: Agnieszka Adamska, et al.
Published: (2021-07-01)
Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome
by: Juan Du, et al.
Published: (2021-02-01)
by: Juan Du, et al.
Published: (2021-02-01)
The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study
by: Menghui Zhang, et al.
Published: (2023-02-01)
by: Menghui Zhang, et al.
Published: (2023-02-01)
Comparison of the effects of laparoscopic sleeve gastrectomy and endoscopic intragastric balloon placement on hormone profile and menstrual cycle in obese women with polycystic ovary syndrome
by: Omer Tammo, et al.
Published: (2025-07-01)
by: Omer Tammo, et al.
Published: (2025-07-01)
Bibliometric analysis of the research on anti-Müllerian hormone and polycystic ovary syndrome: current status, hotspots, and trends
by: Bingqing Ran, et al.
Published: (2025-04-01)
by: Bingqing Ran, et al.
Published: (2025-04-01)
Follicular fluid antimullerian hormone (AMH) does not predict IVF outcomes in polycystic ovary syndrome patients
by: Bushra Abu-Fakher, et al.
Published: (2013-06-01)
by: Bushra Abu-Fakher, et al.
Published: (2013-06-01)
Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome
by: Mimouni, Nour El Houda, et al.
Published: (2024-04-01)
by: Mimouni, Nour El Houda, et al.
Published: (2024-04-01)
Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndromeResearch in context
by: Anne-Laure Barbotin, et al.
Published: (2023-04-01)
by: Anne-Laure Barbotin, et al.
Published: (2023-04-01)
Serum Concentrations of Betatrophin and Its Association with Indirect Indices of Insulin Resistance and Beta Cell Function in Women with Polycystic Ovary Syndrome
by: Agnieszka Adamska, et al.
Published: (2017-01-01)
by: Agnieszka Adamska, et al.
Published: (2017-01-01)
Assessing the clinical diagnostic value of anti-Müllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators
by: Li Wang, et al.
Published: (2024-04-01)
by: Li Wang, et al.
Published: (2024-04-01)
The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS
by: Kim van der Ham, et al.
Published: (2023-10-01)
by: Kim van der Ham, et al.
Published: (2023-10-01)
Ovarian reserve and IVF outcomes in patients with inflammatory bowel disease: A systematic review and meta-analysis
by: Honghao Sun, et al.
Published: (2022-08-01)
by: Honghao Sun, et al.
Published: (2022-08-01)
Phosphorylation-stabilized CRTC1 cooperates with CBP and androgen receptor to transactivate AMH expression and drive polycystic ovary syndrome
by: Yunmei Ke, et al.
Published: (2025-06-01)
by: Yunmei Ke, et al.
Published: (2025-06-01)
Effect of metformin on anti-mullerian hormone levels in women with polycystic ovarian syndrome: a systematic review and meta-regression analysis of randomized controlled trials with
by: Mehdi Mehdinezhad Roshan, et al.
Published: (2024-03-01)
by: Mehdi Mehdinezhad Roshan, et al.
Published: (2024-03-01)
AMH predicts miscarriage in non-PCOS but not in PCOS related infertility ART cycles
by: Christopher Arkfeld, et al.
Published: (2023-04-01)
by: Christopher Arkfeld, et al.
Published: (2023-04-01)
The current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
by: Justyna Lipińska, et al.
Published: (2024-02-01)
by: Justyna Lipińska, et al.
Published: (2024-02-01)
Evaluation of Biochemical Serum Markers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Obese Women in Kazakhstan: Is Anti-Müllerian Hormone a Potential Marker?
by: Malika Madikyzy, et al.
Published: (2024-10-01)
by: Malika Madikyzy, et al.
Published: (2024-10-01)
Comparison of the umbilical cord Blood’s anti-Mullerian hormone level in the newborns of mothers with polycystic ovary syndrome (PCOS) and healthy mothers
by: Faezeh Tadaion Far, et al.
Published: (2019-11-01)
by: Faezeh Tadaion Far, et al.
Published: (2019-11-01)
The association of thyroid autoimmunity with ovarian reserve in women with type 1 diabetes with and without polycystic ovary syndrome
by: Agnieszka Łebkowska, et al.
Published: (2024-06-01)
by: Agnieszka Łebkowska, et al.
Published: (2024-06-01)
Study the Effect of Interleukin36 Gamma and AMH in Iraqi Women with PCOS
by: Wafa R. AlFatlawi
Published: (2018-07-01)
by: Wafa R. AlFatlawi
Published: (2018-07-01)
The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
by: Moaz O. Moursi, et al.
Published: (2023-12-01)
by: Moaz O. Moursi, et al.
Published: (2023-12-01)
Effect of High-Intensity Interval Training and Dietary Approaches to Stop Hypertension on Oocyte Reserve Biomarker and Insulin Resistance in Obese Women With Polycystic Ovary Syndrome
by: Hassan Pourrazi, et al.
Published: (2025-01-01)
by: Hassan Pourrazi, et al.
Published: (2025-01-01)
Anti Mullerian Hormone: A Potential Marker for Recruited Non Growing Follicle of Ovarian Pool in Women with Polycystic Ovarian Syndrome
by: P Saikumar, et al.
Published: (2013-09-01)
by: P Saikumar, et al.
Published: (2013-09-01)
The effect of liraglutide on metabolic and reproductive outcomes in infertile women with PCOS: A prospective cohort study
by: Rossella Cannarella, et al.
Published: (2025-09-01)
by: Rossella Cannarella, et al.
Published: (2025-09-01)
Editorial: Insights in female reproductive longevity
by: Takashi Minegishi
Published: (2025-02-01)
by: Takashi Minegishi
Published: (2025-02-01)
Impact of increasing antimüllerian hormone level on in vitro fertilization fresh transfer and live birth rate
by: Kelly S. Acharya, M.D., et al.
Published: (2022-09-01)
by: Kelly S. Acharya, M.D., et al.
Published: (2022-09-01)
Correlation between Glycated Hemoglobin Levels with Polycystic Ovary Syndrome Phenotypes and Metabolic Syndrome
by: Haviz Yuad, et al.
Published: (2022-08-01)
by: Haviz Yuad, et al.
Published: (2022-08-01)
Association of Polycystic Ovary Syndrome with Clinical, Physical, and Reproductive Factors: A Data-Driven Analysis
by: Ismat Ara Begum, et al.
Published: (2025-03-01)
by: Ismat Ara Begum, et al.
Published: (2025-03-01)
Prevalence of anti-thyroid peroxidase antibodies among women with polycystic ovary syndrome
by: Zahra Rasoulizadeh, et al.
Published: (2025-09-01)
by: Zahra Rasoulizadeh, et al.
Published: (2025-09-01)
The Comparative Effects of Myo-Inositol and Metformin Therapy on the Clinical and Biochemical Parameters of Women of Normal Weight Suffering from Polycystic Ovary Syndrome
by: Aleksandra Gudović, et al.
Published: (2024-02-01)
by: Aleksandra Gudović, et al.
Published: (2024-02-01)
Comparison of maternal and fetal complications in women with various phenotypes of polycystic ovary syndrome
by: Marzieh Rostami Dovom, et al.
Published: (2020-05-01)
by: Marzieh Rostami Dovom, et al.
Published: (2020-05-01)
Thyroid autoimmunity is strongly associated with embryo quality in infertile euthyroid women receiving IVF/ICSI, especially patients with TSH values above 2.5 uIU/mL and poor ovarian response
by: Yimeng Lu, et al.
Published: (2025-10-01)
by: Yimeng Lu, et al.
Published: (2025-10-01)
Association of maternal thyroid peroxidase antibody during pregnancy with placental morphology and inflammatory and oxidative stress responses
by: Xue Ru, et al.
Published: (2023-09-01)
by: Xue Ru, et al.
Published: (2023-09-01)
Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes
by: Alexander M. Kotlyar, et al.
Published: (2023-08-01)
by: Alexander M. Kotlyar, et al.
Published: (2023-08-01)
Evaluating Mirna-222 Expression Level and Its Association with AMH for Early Diagnosis of Pcos-Like Symptoms in Epileptic Patients Plasma Treated with Sodium Valproate: A Case – Control Study
by: Mahya Rajabi, et al.
Published: (2022-01-01)
by: Mahya Rajabi, et al.
Published: (2022-01-01)
Similar Items
-
Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics
by: Minhthao Thi Nguyen, et al.
Published: (2023-01-01) -
Anti-Müllerian hormone and luteinizing hormone for prediction of spontaneous ovulation after laparoscopic ovarian drilling in clomiphene-resistant polycystic ovary syndrome
by: Mohamed Rezk, et al.
Published: (2016-06-01) -
Increased Serum AMH in a Subgroup of Women with Idiopathic Hyperandrogenism: Do These Women Have PCOS?
by: Enrico Carmina, et al.
Published: (2025-08-01) -
Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
by: Youran Li, et al.
Published: (2022-06-01) -
The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis
by: Zhijiao Zhou, et al.
Published: (2023-06-01)
